JBT101-SSc-002: A Multicenter, Randomized, Double-Blind,

Project: Research project

Project Details

Description

JBT101-SSc-002: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
StatusActive
Effective start/end date10/1/1712/31/20

Funding

  • CORBUS PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.